175 related articles for article (PubMed ID: 19452574)
1. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.
Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A
World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574
[TBL] [Abstract][Full Text] [Related]
2. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
[TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
[TBL] [Abstract][Full Text] [Related]
4. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
[TBL] [Abstract][Full Text] [Related]
6. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study.
Flick ED; Habel LA; Chan KA; Haque R; Quinn VP; Van Den Eeden SK; Sternfeld B; Orav EJ; Seeger JD; Quesenberry CP; Caan BJ
Drugs; 2009 Jul; 69(11):1445-57. PubMed ID: 19634923
[TBL] [Abstract][Full Text] [Related]
7. Statin and NSAID use and prostate cancer risk.
Coogan PF; Kelly JP; Strom BL; Rosenberg L
Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):752-5. PubMed ID: 20582910
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.
Kho PF; Fawcett J; Fritschi L; Risch H; Webb PM; Whiteman DC; Neale RE
Cancer Causes Control; 2016 Dec; 27(12):1457-1464. PubMed ID: 27817122
[TBL] [Abstract][Full Text] [Related]
10. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
11. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study.
Hoffmeister M; Chang-Claude J; Brenner H
Int J Cancer; 2007 Sep; 121(6):1325-30. PubMed ID: 17487832
[TBL] [Abstract][Full Text] [Related]
12. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B
PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322
[TBL] [Abstract][Full Text] [Related]
13. Statin use and the risk of colorectal cancer: a population-based case-control study.
Cheng MH; Chiu HF; Ho SC; Tsai SS; Wu TN; Yang CY
World J Gastroenterol; 2011 Dec; 17(47):5197-202. PubMed ID: 22215945
[TBL] [Abstract][Full Text] [Related]
14. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.
Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR
Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250
[TBL] [Abstract][Full Text] [Related]
15. Statins and the risk of colorectal cancer.
Poynter JN; Gruber SB; Higgins PD; Almog R; Bonner JD; Rennert HS; Low M; Greenson JK; Rennert G
N Engl J Med; 2005 May; 352(21):2184-92. PubMed ID: 15917383
[TBL] [Abstract][Full Text] [Related]
16. The causes and effects of socio-demographic exclusions from clinical trials.
Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
18. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
19. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
Xiao H; Yang CS
Int J Cancer; 2008 Sep; 123(5):983-90. PubMed ID: 18548583
[TBL] [Abstract][Full Text] [Related]
20. For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes.
Siddiqui AA; Nazario H; Mahgoub A; Patel M; Cipher D; Spechler SJ
Dig Dis Sci; 2009 Jun; 54(6):1307-11. PubMed ID: 19337834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
